Â鶹´«Ã½

    Advertisement
    In the last 4 hours
    TipRanks16:29
    Earlier today
    FiercePharma08:39
    In the last 7 days
    TipRanks16:50 2-Apr-25
    The New European22:27 1-Apr-25
    Nasdaq16:59 1-Apr-25
    Law36016:01 28-Mar-25
    ENDPOINTS08:09 28-Mar-25
    In the last month
    TipRanks17:07 27-Mar-25
    Bloomberg Law16:32 27-Mar-25
    DGAP16:19 27-Mar-25
    GlobeNewswire (Press Release)10:00 25-Mar-25
    IPWatchdog.com14:14 23-Mar-25
    GlobeNewswire (Press Release)13:43 20-Mar-25
    FierceBiotech09:52 20-Mar-25
    GlobeNewswire (Press Release)07:06 20-Mar-25
    Seeking Alpha11:51 19-Mar-25
    TipRanks20:27 11-Mar-25
    Nasdaq18:34 11-Mar-25
    TipRanks00:05 11-Mar-25
    Law.com16:30 10-Mar-25
    FiercePharma15:46 10-Mar-25
    Anadolu Agency15:29 10-Mar-25
    ENDPOINTS14:38 10-Mar-25
    Scrip Pharma Intelligence14:06 10-Mar-25
    Yahoo! US12:17 10-Mar-25
    Benzinga10:27 10-Mar-25
    TipRanks10:11 10-Mar-25
    KELO TV09:19 10-Mar-25
    The Motley Fool08:52 10-Mar-25
    RTT News08:49 10-Mar-25
    TipRanks07:17 10-Mar-25
    BioNTech (Press Release)06:56 10-Mar-25
    Benzinga02:19 10-Mar-25
    Benzinga10:28 7-Mar-25
    IPWatchdog.com17:15 6-Mar-25
    Skeptical Raptor16:20 6-Mar-25
    Scrip Pharma Intelligence13:35 6-Mar-25
    FiercePharma11:05 6-Mar-25
    Law36015:47 5-Mar-25
    Bloomberg Law13:14 5-Mar-25
    ENDPOINTS10:13 5-Mar-25
    Yahoo! US10:09 5-Mar-25
    Clinical Trials Arena09:59 5-Mar-25
    KELO TV07:55 5-Mar-25
    FierceBiotech01:46 5-Mar-25
    view more headlines
    4 Apr 16:29

    About our BioNTech news

    Latest news on BioNTech, a German biotechnology company that makes active immunotherapies for patient-specific approaches to the treatment of diseases.


    Publication filters

    Headline Density

    Sorry, no headlines or news topics were found. Please try different keywords.